Search Results for "Recall Promus Heart Stent"

11:20 EST 29th January 2015 | BioPortfolio

Matching Channels

BioMimics 3D™ Stent

Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...

Brilinta (TM) - ticagrelor, AstraZeneca's new heart drug

Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...

Aorfix

Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...

Heart Transplantation

Heart Failure HF

Matching News

Added Value of Biodegradable-Polymer DES Questioned

Researchers said they saw no advantage against late stent thrombosis for the biodegradable-polymer Nobori stent. In a different study, the Synergy stent was noninferior to the Promus Prime DES. Hear...

Boston Scientific's Synergy stent passes Evolve II trial

Boston Scientific's Synergy stent passed the Evolve II trial, where it was put against drug-eluting stent Promus, the company -More- 

Boston Scientific Launches Stent Trial In Underserved Populations

PLATINUM Diversity trial will examine Promus Premier stent in women and people of color, populations that have been underrepresented in previous trials. The trial coincides with the company’s Close ...

Extended anti-clotting therapy cut heart attacks after stent -study

CHICAGO, Nov 16 (Reuters) - Patients who took two anti-clotting drugs for 30 months after undergoing a heart stent placement significantly cut their risk of heart attacks and blood clots in the stent ...

Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

Abbott's Absorb Bioresorbable Vascular Scaffold (BVS) is a revolutionary medical device, used in the heart, that functions like a stent but dissolves over time One-year results show Absorb provides co...

Heart Sync's defibrillator electrode recall labeled Class I by FDA

A recall initiated by Michigan firm Heart Sync on Nov.  -More- 

Abbott dissolving stent has lower angina rate vs metal stent: study

(Reuters) - Abbott's Absorb dissolving heart stent proved as safe and effective one year after being placed in a diseased artery as the company's market-leading Xience drug coated metal stent with a s...

Abbott dissolving stent has lower angina rate vs metal stent -study

Sept 14 (Reuters) - Abbott's Absorb dissolving heart stent proved as safe and effective one year after being placed in a diseased artery as the company's market-leading Xience drug coated metal stent ...

Matching PubMed Articles

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type.

To investigate the putative modifying effect of dual antiplatelet therapy (DAPT) use on the incidence of stent thrombosis at 3 years in patients randomized to Endeavor zotarolimus-eluting stent (E-ZES...

Outcomes of everolimus-eluting stent incomplete stent apposition: a serial optical coherence tomography analysis.

The aim of the present study was to evaluate the natural course of acute incomplete stent apposition (ISA) after second-generation everolimus-eluting stent (EES) when compared with first-generation si...

Spectral Analysis Related to Bare-Metal and Drug-Eluting Coronary Stent Implantation.

Background: The autonomic nervous system plays a central role in cardiovascular regulation; sympathetic activation occurs during myocardial ischemia. Objective: To assess the spectral analysis of hear...

Bioresorbable vascular scaffold for coronary in-stent restenosis: A novel concept.

The management of patients with significant in-stent restenosis (ISR) with drug-eluting stent is still not well defined. Various treatment modalities include plain old balloon angioplasty (POBA), meta...

Stent intussusception after thromboaspiration through a platinum chrome stent: a particular case of longitudinal stent deformation.

The need to improve stent deliverability has led to the development of thinner and more flexible stents. However, there is concern about decreased longitudinal strength. The number of longitudinal ste...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement